Schedule 13G ownership disclosure

BioAge Labs Inc

Security class unavailable · CUSIP: 09077V100

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,331,072
Percent of class
6.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-116796
Form type
SC 13G
Filer
BioAge Labs, Inc.
CIK
CIK 1709941
Filed
Nov 12, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub